GLDC expression is usually upregulated in tumor patients, playing a critical role in tumorigenesis and cancer progression, such as in breast and lung cancers, hepatocellular carcinoma, and leukemia [44–46]. The gene discussed is GLDC; the disease is hepatocellular carcinoma.